Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AORT NYSE:GKOS NASDAQ:IRTC NYSE:STVN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAORTArtivion$40.68-3.9%$37.46$21.97▼$45.07$1.92B1.7416,571 shs432,541 shsGKOSGlaukos$82.74-5.4%$93.48$77.10▼$163.71$5.02B0.77636,786 shs883,604 shsIRTCiRhythm Technologies$179.82-0.7%$156.38$55.92▼$187.57$5.82B1.1385,324 shs232,437 shsSTVNStevanato Group€26.43-1.6%€24.24€17.12▼€28.00€8.00B0.55350,168 shs542,400 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAORTArtivion0.00%-6.31%-5.31%+44.20%+67.20%GKOSGlaukos0.00%-11.73%-9.07%-15.30%-34.07%IRTCiRhythm Technologies0.00%-0.68%+10.93%+25.01%+140.30%STVNStevanato Group0.00%+9.53%+18.89%+12.95%+30.84%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAORTArtivion$40.68-3.9%$37.46$21.97▼$45.07$1.92B1.7416,571 shs432,541 shsGKOSGlaukos$82.74-5.4%$93.48$77.10▼$163.71$5.02B0.77636,786 shs883,604 shsIRTCiRhythm Technologies$179.82-0.7%$156.38$55.92▼$187.57$5.82B1.1385,324 shs232,437 shsSTVNStevanato Group€26.43-1.6%€24.24€17.12▼€28.00€8.00B0.55350,168 shs542,400 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAORTArtivion0.00%-6.31%-5.31%+44.20%+67.20%GKOSGlaukos0.00%-11.73%-9.07%-15.30%-34.07%IRTCiRhythm Technologies0.00%-0.68%+10.93%+25.01%+140.30%STVNStevanato Group0.00%+9.53%+18.89%+12.95%+30.84%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAORTArtivion 3.00Buy$40.63-0.11% DownsideGKOSGlaukos 2.79Moderate Buy$124.8350.87% UpsideIRTCiRhythm Technologies 3.00Buy$163.82-8.90% DownsideSTVNStevanato Group 2.83Moderate BuyN/AN/ACurrent Analyst Ratings BreakdownLatest AORT, STVN, GKOS, and IRTC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/10/2025GKOSGlaukosBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$118.008/28/2025IRTCiRhythm TechnologiesNeedham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$180.00 ➝ $193.008/22/2025AORTArtivionNeedham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$45.00 ➝ $50.008/21/2025IRTCiRhythm TechnologiesCitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$167.00 ➝ $183.008/20/2025IRTCiRhythm TechnologiesBank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$200.008/15/2025GKOSGlaukosZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold8/13/2025AORTArtivionLADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Neutral$32.00 ➝ $38.808/8/2025AORTArtivionOppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform8/8/2025AORTArtivionCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$35.00 ➝ $41.008/8/2025AORTArtivionJMP SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetMarket Outperform$33.00 ➝ $42.008/8/2025AORTArtivionStifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$36.00 ➝ $40.00(Data available from 9/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAORTArtivion$405.04M4.74$0.80 per share50.71$6.59 per share6.17GKOSGlaukos$383.48M12.37N/AN/A$13.91 per share5.95IRTCiRhythm Technologies$657.23M8.79N/AN/A$2.90 per share62.01STVNStevanato Group€1.19B6.70€0.74 per share35.60€5.02 per share5.26Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAORTArtivion-$13.36M-$0.42N/A81.36N/A-4.43%5.70%2.29%11/6/2025 (Estimated)GKOSGlaukos-$146.37M-$1.65N/AN/AN/A-21.43%-8.59%-6.61%11/3/2025 (Estimated)IRTCiRhythm Technologies-$113.29M-$2.93N/AN/AN/A-14.06%-90.03%-8.52%10/29/2025 (Estimated)STVNStevanato Group€127.45M€0.5448.9545.572.5311.73%10.34%6.21%N/ALatest AORT, STVN, GKOS, and IRTC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025AORTArtivion$0.11$0.24+$0.13$0.03$107.96 million$112.97 million7/31/2025Q2 2025IRTCiRhythm Technologies-$0.53-$0.32+$0.21-$0.44$173.94 million$186.69 million7/30/2025Q2 2025GKOSGlaukos-$0.26-$0.24+$0.02-$0.34$115.49 million$124.12 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAORTArtivionN/AN/AN/AN/AN/AGKOSGlaukosN/AN/AN/AN/AN/AIRTCiRhythm TechnologiesN/AN/AN/AN/AN/ASTVNStevanato GroupN/AN/AN/AN/A1 YearsCompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAORTArtivion0.524.783.48GKOSGlaukos0.095.514.69IRTCiRhythm Technologies6.255.024.88STVNStevanato Group0.251.791.22Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAORTArtivion86.37%GKOSGlaukos99.04%IRTCiRhythm TechnologiesN/ASTVNStevanato GroupN/AInsider OwnershipCompanyInsider OwnershipAORTArtivion7.60%GKOSGlaukos5.80%IRTCiRhythm Technologies1.10%STVNStevanato Group0.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAORTArtivion1,60047.18 million43.60 millionOptionableGKOSGlaukos78057.35 million54.02 millionOptionableIRTCiRhythm Technologies2,00032.13 million31.78 millionOptionableSTVNStevanato Group5,521302.84 million300.72 millionOptionableAORT, STVN, GKOS, and IRTC HeadlinesRecent News About These CompaniesAlliancebernstein L.P. Lowers Stock Position in Stevanato Group S.p.A. $STVNSeptember 13 at 3:40 AM | marketbeat.comStevanato Group SpA (STVN) Share Gained 20% as Results Exceeded ExpectationsSeptember 12 at 8:51 AM | insidermonkey.comStevanato (STVN) Upgraded to Buy: Here's What You Should KnowSeptember 11 at 1:01 PM | zacks.comStevanato Group Joins Rank Of Stocks With 95-Plus Composite RatingSeptember 10, 2025 | msn.comVancity Investment Management Ltd Buys Shares of 52,642 Stevanato Group S.p.A. $STVNSeptember 10, 2025 | marketbeat.comFred Alger Management LLC Sells 25,039 Shares of Stevanato Group S.p.A. $STVNSeptember 10, 2025 | marketbeat.comStevanato Group S.p.A. (STVN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 9, 2025 | seekingalpha.comGranahan Investment Management LLC Sells 110,512 Shares of Stevanato Group S.p.A. $STVNSeptember 8, 2025 | marketbeat.comStevanato Group (STVN) Gets a Buy from CitiSeptember 6, 2025 | theglobeandmail.comFinancial Contrast: Siga Technologies (NASDAQ:SIGA) and Stevanato Group (NYSE:STVN)September 6, 2025 | americanbankingnews.comStevanato Group (NYSE:STVN) Shares Up 7.6% - Here's What HappenedSeptember 5, 2025 | marketbeat.comStevanato Group to Participate in Upcoming Investor ConferencesSeptember 2, 2025 | businesswire.comStevanato Group S.p.A. $STVN Shares Purchased by Raymond James Financial Inc.September 2, 2025 | marketbeat.comTri Locum Partners LP Decreases Stake in Stevanato Group S.p.A. $STVNAugust 30, 2025 | marketbeat.comChamplain Investment Partners LLC Takes $15.74 Million Position in Stevanato Group S.p.A. $STVNAugust 30, 2025 | marketbeat.comRussell Investments Group Ltd. Purchases 91,663 Shares of Stevanato Group S.p.A. $STVNAugust 29, 2025 | marketbeat.comUSNA or STVN: Which Is the Better Value Stock Right Now?August 28, 2025 | zacks.com633,887 Shares in Stevanato Group S.p.A. $STVN Purchased by MetLife Investment Management LLCAugust 28, 2025 | marketbeat.comHere’s Why Artisan Small Cap Fund Increased its Holdings in Stevanato Group S.p.A. (STVN)August 25, 2025 | insidermonkey.comT. Rowe Price Investment Management Inc. Has $76.47 Million Stock Position in Stevanato Group S.p.A. $STVNAugust 25, 2025 | marketbeat.comInvesco Ltd. Invests $19.07 Million in Stevanato Group S.p.A. $STVNAugust 24, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAORT, STVN, GKOS, and IRTC Company DescriptionsArtivion NYSE:AORT$40.68 -1.63 (-3.85%) Closing price 09/12/2025 03:59 PM EasternExtended Trading$40.69 +0.01 (+0.02%) As of 09/12/2025 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts including E-vita Open Plus and E-vita Open Neo. It offers E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, a stent graft system for the treatment of infrarenal abdominal aortic aneurysms. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.Glaukos NYSE:GKOS$82.74 -4.73 (-5.41%) Closing price 09/12/2025 03:59 PM EasternExtended Trading$83.26 +0.52 (+0.63%) As of 09/12/2025 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.iRhythm Technologies NASDAQ:IRTC$179.82 -1.21 (-0.67%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$177.00 -2.82 (-1.57%) As of 09/12/2025 06:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.Stevanato Group NYSE:STVN€26.43 -0.44 (-1.64%) As of 09/12/2025 03:59 PM EasternStevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/08 - 09/12 Meta's $600B U.S. Investment: Bearish or Bullish for Shares? Football Season Is Here and DraftKings Stock Is Surging RH Stock Slides After Mixed Earnings and Tariff Concerns Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
